Status:
COMPLETED
Prevention of Ovarian Cancer in Women Participating in Mammography
Lead Sponsor:
Fred Hutchinson Cancer Center
Collaborating Sponsors:
Swedish Medical Center
Conditions:
Epithelial Ovarian Cancer
Eligibility:
FEMALE
35+ years
Phase:
NA
Brief Summary
The primary purpose of this study is to evaluate the effect of systematic identification and genetic counseling referral on rates of bilateral salpingo-oophorectomy (surgery to remove both fallopian t...
Eligibility Criteria
Inclusion
- Prior mammogram at Swedish Medical Center
- Willing and able to provide informed consent, primary physician information, and complete study questionnaires
- Must meet at least ONE of the following criteria:
- personal history of breast cancer diagnosed before age 50
- personal history of bilateral breast cancer at any age
- 1 or more first degree relatives with breast cancer diagnosed before age 50
- 3 or more first or second degree relatives with breast cancer at any age
- 2 second degree relatives with breast cancer diagnosed before age 50
- A male relative with breast cancer at any age
- Ashkenazi Jewish with any family history of breast or ovarian cancer
- 1 first or second degree relative with ovarian cancer AND 1 first or second degree relative with breast cancer at any age
- 2 first degree relatives with ovarian cancer or 2 second degree relatives with ovarian cancer or 1 first and 1 second degree relative with ovarian cancer.
- A first degree relative with both breast and ovarian cancer (2 primaries in the same person)
- Personal history of positive genetic test result for any of the following genes: BRCA1, BRCA2, HNPCC, or P53
- Family history of a positive genetic test result for any of the following genes: BRCA1, BRCA2 or HNPCC
Exclusion
- Previous diagnosis of ovarian cancer
- Prior bilateral-salpingo oophorectomy
- Had a negative genetic test result for a known family genetic mutation
Key Trial Info
Start Date :
July 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
458 Patients enrolled
Trial Details
Trial ID
NCT01851109
Start Date
July 1 2008
End Date
December 1 2015
Last Update
January 28 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fred Hutchinson Cancer Research Center
Seattle, Washington, United States, 98109